Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01279811 · ClinicalTrials.gov registry record · NA

The Canadian Multicentre CSF Monitoring and Biomarker Study

A NA study, sponsored by University of British Columbia.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT01279811 is a NA study that has completed, run by University of British Columbia. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01279811, a NA study, has completed, sponsored by University of British Columbia.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

The purpose of this study is to: 1. Measure the pressure in the spinal fluid surrounding the spinal cord to find out how well the spinal cord is being supplied with blood. 2. Determine how drugs called "vasopressors", which are used to control blood pressure following SCI (spinal cord injury), influence spinal fluid pressure. 3. Characterize the severity of an SCI using the levels of specific proteins found within the spinal fluid. 4. Predict how much neurologic recovery may be regained using the levels of specific proteins within your spinal fluid. 5. Identify proteins within the spinal fluid that will help us learn more about what is happening after SCI and assist us in developing new treatments for SCI.

Interventions

  • OTHER Crossover of vasopressors

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-01
Est. Completion 2020-09-30
Phase NA

Sponsor

University of British Columbia

18 total trials

What the Registry Record Tells You About NCT01279811

The ClinicalTrials.gov registry entry for NCT01279811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of British Columbia, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Crossover of vasopressors is the first listed.

NCT01279811 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01279811 about?

NCT01279811 is a clinical study titled "The Canadian Multicentre CSF Monitoring and Biomarker Study". The purpose of this study is to: 1. Measure the pressure in the spinal fluid surrounding the spinal cord to find out how well the spinal cord is being supplied with blood. 2. Determine how drugs called "vasopressors", which are used to control blood pressure following SCI (spinal cord injury), infl...

What is the current status of trial NCT01279811?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-01. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT01279811?

The interventions under investigation include: Crossover of vasopressors (OTHER).

Who is sponsoring clinical trial NCT01279811?

This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.